Two 6-week, randomized, double-blind, placebo-controlled studies of ziprasidone in outpatients with bipolar i depression: Did baseline characteristics impact trial outcome?

Journal of Clinical Psychopharmacology

Volumn 32, Issue 4, 2012, Pages 470-478

  Lombardo, Ilise ^a   Sachs, Gary ^b,c   Kolluri, Sheela ^a   Kremer, Charlotte ^a   Yang, Ruoyong ^a  

^a PFIZER INC   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

Atypical antipsychotic; Bipolar depression; Placebo response

Indexed keywords

BENZATROPINE; ESZOPICLONE; PROPRANOLOL; RAMELTEON; ZALEPLON; ZIPRASIDONE; ZOLPIDEM;

AKATHISIA; ARTICLE; BIPOLAR I DISORDER; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; HAMILTON SCALE; HUMAN; INSOMNIA; OUTPATIENT; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT FAILURE;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; OUTPATIENTS; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; THIAZOLES; TREATMENT OUTCOME;

EID: 84863722984     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31825ccde5     Document Type: Article

References (25)

1. McElroy SL, Weisler RH, Chang W, et al. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J Clin Psychiatry. 2010;71:163-174.
2. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007;356:1711-1722. (Pubitemid 46658703)
3. Altshuler L, Suppes T, Black D, et al. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry. 2003;160:1252-1262. (Pubitemid 41070941)
4. Calabrese JR, Bowden CL, Sachs GS, et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry. 1999;60:79-88. (Pubitemid 29104383)
5. Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry. 2003;60:1079-1088. (Pubitemid 37429647)
6. Calabrese JR, Keck PE, Jr., Macfadden W, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry. 2005;162:1351-1360. (Pubitemid 40905587)
7. Thase ME, Macfadden W, Weisler RH, et al. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol. 2006;26:600-609. (Pubitemid 44772737)
8. Cruz N, Sanchez-Moreno J, Torres F, et al. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis. Int J Neuropsychopharmacol. 2010;13:5-14.
9. Thase ME, Jonas A, Khan A, et al. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies. J Clin Psychopharmacol. 2008;28:13-20.
10. Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry. 2009;194:4-9.
11. Fava M, Evins AE, Dorer DJ, et al. The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach. Psychother Psychosom. 2003;72:115-127. (Pubitemid 36469860)
12. Sysko R, Walsh BT. A systematic review of placebo response in studies of bipolar mania. J Clin Psychiatry. 2007;68:1213-1217. (Pubitemid 47395623)
13. Mundt JC, Greist JH, Jefferson JW, et al. Is it easier to find what you are looking for if you think you know what it looks like? J Clin Psychopharmacol. 2007;27:121-125. (Pubitemid 46594927)
14. Liebowitz MR, Salman E, Mech A, et al. Ziprasidone monotherapy in bipolar II depression: an open trial. J Affect Disord. 2009;118:205-208.
15. Papakostas GI, Petersen TJ, Nierenberg AA, et al. Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder. J Clin Psychiatry. 2004;65:217-221.
16. Schmidt AW, Lebel LA, Howard HR Jr, et al. Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Eur J Pharmacol. 2001;425:197-201. (Pubitemid 32770067)
17. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IVand ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33. (Pubitemid 29001829)
18. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278-296.
19. Young RC, Biggs JT, Ziegler VT, et al. A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry. 1978;133:429-435. (Pubitemid 9006756)
20. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389. (Pubitemid 9136500)
21. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl. 1970;212:11-19.
22. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry. 1989;154:672-676. (Pubitemid 19154942)
23. Zimmerman M, Posternak MA, Chelminski I. Derivation of a definition of remission on the Montgomery-Asberg Depression Rating Scale corresponding to the definition of remission on the Hamilton Rating Scale for Depression. J Psychiatr Res. 2004;38:577-582. (Pubitemid 39348889)
24. Nemeroff CB, Lieberman JA,Weiden PJ, et al. From clinical research to clinical practice: a 4-year review of ziprasidone. CNS Spectr. 2005;10(11 suppl 17):1-20.
25. Clinical Study Report, Bristol Myers Squibb. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole in the Treatment of Patients with Bipolar I Disorder with a Major Depressive Episode. Study 1: CN138096; http://ctr.bms.com/pdf//CN138096.pdf. Study 2: CN138146; http://ctr.bms.com/pdf//CN138146.pdf.